Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy - Wikidata - awgldk - TriplyDB

Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy

Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy

http://www.wikidata.org/entity/Q27021701

about

Ocular Complications of Diabetes and Therapeutic Approaches Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein.Serum and vitreous levels of visfatin in patients with diabetic retinopathy Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients.Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.RNA sequencing reveals retinal transcriptome changes in STZ-induced diabetic rats.Inflammatory cytokine-specific alterations in retinal endothelial cell function.The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy.Inflammation and pharmacological treatment in diabetic retinopathy.From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy Inflammatory markers and cardiometabolic diseases.Diabetic Retinopathy: Vascular and Inflammatory Disease.Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy.Negative regulators of angiogenesis: important targets for treatment of exudative AMD.Severe prelenticular membrane formation on the surface of a hydrophilic acrylic intraocular lens after cataract surgery in an eye with an Ahmed valve implant.Retinal microangiopathy in a mouse model of inducible mural cell loss.Angiogenic Factors and Cytokines in Diabetic Retinopathy.Angiogenin gene polymorphism: A risk factor for diabetic peripheral neuropathy in the northern Chinese Han population.Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy.The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy.The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.

P2860

Q26749412-0AC64725-4668-4F33-AC1F-6E6E67974040 Q33739264-3F498EBB-7CA8-4F91-9842-31DF7AFE0C2E Q33914624-F1E53DC3-877B-46DD-917D-4C6B8AE934A0 Q34789505-54515975-5DFE-46FB-9E43-5570C008C5A8 Q35035441-376F9C25-18B4-4DF6-861E-1E783056438F Q35055667-6FDF7803-61CD-4D3C-9A52-498943AC9163 Q35768068-7C70417D-3903-4C57-9FB1-74F8D343E2D4 Q35962884-1D07B7EA-E6EA-49C2-906A-1E898A27E362 Q36048817-A45F77AC-F7A7-44D4-A5E2-208767922783 Q36624029-F6BC2517-6458-453A-AA9D-21693CFF0B00 Q37150614-C9AD819D-C683-406B-8933-1459DF35884F Q37247435-2B77A033-B882-4172-957B-3542B02FB7D5 Q38167309-C8059AD2-1B2D-4C8D-B4F0-773F1ECE74CA Q38332124-7F0F31D5-299C-4470-8410-C28060199062 Q38535519-22240A27-C283-45D8-858E-2064B45E7999 Q38542115-0772BE40-C261-4B74-98A8-3929008F89E5 Q38748869-7FFCB54B-7865-40C0-BD44-A999345C8839 Q39416208-725F5C38-CD74-4DBD-968B-DEE8A1EF63D5 Q40050505-7E4E48BC-3B05-4961-956B-65BFFC289CCC Q41816335-CA3E5F07-C6C9-4AD8-B2FD-4C0ECB5DC6A4 Q41883466-287A1C98-D26A-449C-AF2E-B24F38DFA1BD Q42084622-98499050-91DE-4F6E-B22C-78CEF19FB85B Q53111788-4A36E926-0BCC-4F7E-93DA-1F6BF17FDBDB Q53380645-1776C01C-E2F8-4D1D-85B3-86CF978AC0A7 Q55003873-65CDA942-F337-489B-9462-EFA715405CB7 Q55183262-77DA6F6D-18CD-4A42-9774-575AB1A931E5

P2860

Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy

http://www.wikidata.org/entity/Q27021701

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Therapeutic interventions agai ...... iferative diabetic retinopathy

@ast

Therapeutic interventions agai ...... iferative diabetic retinopathy

@en

Therapeutic interventions agai ...... iferative diabetic retinopathy

@nl

type

label

Therapeutic interventions agai ...... iferative diabetic retinopathy

@ast

Therapeutic interventions agai ...... iferative diabetic retinopathy

@en

Therapeutic interventions agai ...... iferative diabetic retinopathy

@nl

prefLabel

Therapeutic interventions agai ...... iferative diabetic retinopathy

@ast

Therapeutic interventions agai ...... iferative diabetic retinopathy

@en

Therapeutic interventions agai ...... iferative diabetic retinopathy

@nl

P1433

Q27021701-B3771A25-2715-4888-AC06-609619A2099A

P1476

Q27021701-040F581B-C3E6-4CBA-BF89-945F9FCEA440

P2093

Q27021701-49C7E9FB-134A-4BBC-B1CB-DB6F550BE222

Q27021701-E07BE5AB-570E-49F0-9455-519A7FF37A95

P275

Q27021701-5DED0780-EAA3-4E36-9ED0-DCDEA27BFD74

P2860

Q27021701-01B0922D-846C-49D8-84C5-7D2A2D0C7864

Q27021701-06618689-C3BA-466A-A4C0-392DA0A5B108

Q27021701-076C822D-CFF7-43BF-A12F-35AC718EDBAB

Q27021701-07774FCF-DD94-46B9-A172-B311F832788A

Q27021701-07B005AA-510F-45F6-87E1-68BC0EA607F5

Q27021701-0B73240B-0699-4F68-BEA5-3D78ECF15643

Q27021701-1682F05C-18BA-45CD-B704-9C45869516C3

Q27021701-184BA64B-C3F6-42FC-AE48-EC7BFEB4B223

Q27021701-1F4E938F-F4A0-4F89-80C0-42DB6FDCFD5A

Q27021701-203A51EA-ACD8-44C2-90F2-A04D6FF0618A

P304

Q27021701-89113350-C4E0-47EE-944C-09C89A5C201E

P31

Q27021701-B08E6806-9F6D-41A2-A0EC-B65798D09657

P3181

Q27021701-10FAEB6D-029E-4F7A-8FEF-8FB7F23BB02F

P356

Q27021701-8F87B391-981D-45AE-ABC8-C6F1BAFBA037

P407

Q27021701-B21C21B0-DDBB-4776-A40C-BA7E9C719B24

P478

Q27021701-66F813A2-0804-4ABE-AAF0-B76ED4E8BB20

P50

Q27021701-C9C514C6-DCB6-4748-88F4-B2E61B94F32B

P5008

Q27021701-0A2B9B33-D346-4236-9789-6227FCA782D1

P577

Q27021701-7B856318-B255-4F0E-B8DB-42DFB3667C4F

P5875

Q27021701-2078816D-45FA-43CE-9939-42683B0FF671

P698

Q27021701-C8DA16D9-828E-4C94-849B-ABB96A5F6C44

P921

Q27021701-402A165A-CFF4-4071-97B4-E7B19081E21C

Q27021701-AB6127CB-BC77-4BC9-A75B-A41570DDEDBD

Q27021701-D2B83031-BE2D-4937-971F-302CAE1E7815

P932

Q27021701-17C097F1-C844-4CF1-B4B7-28FEA660B709

P3181

P356

P1433

Mediators of Inflammation

P1476

Therapeutic interventions agai ...... iferative diabetic retinopathy

@en

P2093

Aristomenis Thanos

http://www.w3.org/2001/XMLSchema#string

Daniel Gologorsky

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier

Fenofibrate - a potential systemic treatment for diabetic retinopathy?

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Global estimates of the prevalence of diabetes for 2010 and 2030

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

P304

629452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3576622

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2012/629452

http://www.w3.org/2001/XMLSchema#string

P407

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Demetrios Vavvas

P5008

P577

2012-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231742817

http://www.w3.org/2001/XMLSchema#string

P698

23028203

http://www.w3.org/2001/XMLSchema#string

P921

diabetic retinopathy

P932

3457666

http://www.w3.org/2001/XMLSchema#string